miR-221/222 Compensates for Skp2-Mediated p27 Degradation and Is a Primary Target of Cell Cycle Regulation by Prostacyclin and cAMP
Paola A. Castagnino(Thomas Jefferson University), Richard K. Assoian(Translational Therapeutics (United States))
Cited by 19
Related Papers
Sigma1 inhibitor suppression of adaptive immune resistance mechanisms mediated by cancer cell derived extracellular vesicles
|Cancer Biology & Therapy|2025|6
Systematic analysis of IL-1 cytokine signaling by high-risk HPV oncoproteins
|bioRxiv (Cold Spring Harbor Laboratory)|2022|0